Arvinas, Inc. (ARVN)
NASDAQ: ARVN · Real-Time Price · USD
11.09
-0.08 (-0.72%)
Mar 20, 2026, 1:11 PM EDT - Market open

Arvinas Revenue

In the year 2025, Arvinas had annual revenue of $262.60M, down -0.30%. Arvinas had revenue of $9.50M in the quarter ending December 31, 2025, a decrease of -83.95%.

Revenue (ttm)
$262.60M
Revenue Growth
-0.30%
P/S Ratio
2.72
Revenue / Employee
$1,067,480
Employees
246
Market Cap
709.33M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025262.60M-800.00K-0.30%
Dec 31, 2024263.40M184.90M235.54%
Dec 31, 202378.50M-52.90M-40.26%
Dec 31, 2022131.40M77.80M145.15%
Dec 31, 202153.60M27.70M106.95%
Dec 31, 202025.90M-17.10M-39.77%
Dec 31, 201943.00M28.68M200.20%
Dec 31, 201814.32M6.75M89.00%
Dec 31, 20177.58M909.85K13.64%
Dec 31, 20166.67M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Gyre Therapeutics116.59M
Theravance Biopharma107.46M
Lexicon Pharmaceuticals49.80M
Prime Medicine4.63M
Ocugen4.41M
Revenue Rankings